CVS Caremark decided to stop offering one product in favor of another for weight loss, the latest example of ...

In addition to eliciting greater weight loss than Novo Nordisk’s Wegovy, Eli Lilly’s Zepbound does not come at the expense of ...

The trends worry health experts, who say the medicines have potential to narrow differences in obesity rates among ...

Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...

President Trump's new Executive Order aims to lower prescription drug prices by tying U.S. costs to global rates. Read more ...

Shares in Eli Lilly have weakened after CVS Health, one of the largest pharmacy benefit managers (PBMs) in the US, said it would no longer cover its obesity therapy Zepbound. The shares closed ...

However, it is not the first alliance between the two companies. COVID accelerated coalitions In 2008, CVS Caremark, a prescription benefit management company, signed on to use Microsoft's ...

China and U.S. flags are displayed alongside a miniature worker in this illustration picture taken November 7, 2024. REUTERS/Florence Lo/Illustration/File Photo A look at the day ahead in European ...